Csilla Hegedüs

584 total citations
13 papers, 444 citations indexed

About

Csilla Hegedüs is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Csilla Hegedüs has authored 13 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Csilla Hegedüs's work include Drug Transport and Resistance Mechanisms (12 papers), Cancer therapeutics and mechanisms (4 papers) and Cholesterol and Lipid Metabolism (4 papers). Csilla Hegedüs is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Cancer therapeutics and mechanisms (4 papers) and Cholesterol and Lipid Metabolism (4 papers). Csilla Hegedüs collaborates with scholars based in Hungary, United States and Denmark. Csilla Hegedüs's co-authors include Csilla Özvegy‐Laczka, Balázs Sarkadi, Gergely Szakács, Ágnes Telbisz, András Váradi, Tamás Hegedűs, Anna Brózik, Zsuzsa Erdei, György Várady and Balázs Sarkadi and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Advanced Drug Delivery Reviews.

In The Last Decade

Csilla Hegedüs

13 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Csilla Hegedüs Hungary	11	351	217	69	60	59	13	444
Maria A.J. van Eijndhoven Netherlands	7	356 1.0×	258 1.2×	45 0.7×	52 0.9×	77 1.3×	8	520
Megumi Yoshikawa Japan	9	493 1.4×	288 1.3×	64 0.9×	86 1.4×	133 2.3×	13	574
George Cusatis United States	7	414 1.2×	174 0.8×	41 0.6×	50 0.8×	100 1.7×	8	516
Seiji Doi Japan	12	511 1.5×	365 1.7×	64 0.9×	70 1.2×	78 1.3×	20	737
Stéphanie van Hoppe Netherlands	12	257 0.7×	148 0.7×	67 1.0×	29 0.5×	53 0.9×	15	449
Agnès Basseville United States	11	239 0.7×	321 1.5×	35 0.5×	31 0.5×	31 0.5×	18	521
Guan-Nan Zhang United States	12	277 0.8×	249 1.1×	47 0.7×	63 1.1×	36 0.6×	17	425
Hideyuki Tanimura Japan	12	347 1.0×	297 1.4×	100 1.4×	34 0.6×	54 0.9×	16	574
Tanya Bagrij United Kingdom	8	349 1.0×	141 0.6×	64 0.9×	46 0.8×	145 2.5×	11	433
Kenji Terashi Japan	13	254 0.7×	185 0.9×	35 0.5×	39 0.7×	47 0.8×	21	386

Countries citing papers authored by Csilla Hegedüs

Since Specialization

Citations

This map shows the geographic impact of Csilla Hegedüs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Csilla Hegedüs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Csilla Hegedüs more than expected).

Fields of papers citing papers by Csilla Hegedüs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Csilla Hegedüs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Csilla Hegedüs. The network helps show where Csilla Hegedüs may publish in the future.

Co-authorship network of co-authors of Csilla Hegedüs

This figure shows the co-authorship network connecting the top 25 collaborators of Csilla Hegedüs. A scholar is included among the top collaborators of Csilla Hegedüs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Csilla Hegedüs. Csilla Hegedüs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Urbán, László, Róbert Dóczi, M. Horváth, et al.. (2020). Major Clinical Response to Afatinib Monotherapy in Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion Mutation. Clinical Lung Cancer. 22(1). e112–e115. 8 indexed citations

Hegyi, Zoltán, Szilárd Tóth, Csilla Hegedüs, et al.. (2016). Application of fluorescent dye substrates for functional characterization of ABC multidrug transporters at a single cell level. Cytometry Part A. 89(9). 826–834. 19 indexed citations

Hegedüs, Csilla, Ágnes Telbisz, Tamás Hegedűs, Balázs Sarkadi, & Csilla Özvegy‐Laczka. (2015). Lipid Regulation of the ABCB1 and ABCG2 Multidrug Transporters. Advances in cancer research. 125. 97–137. 35 indexed citations

Hegedüs, Csilla, et al.. (2014). Mutations of the central tyrosines of putative cholesterol recognition amino acid consensus (CRAC) sequences modify folding, activity, and sterol-sensing of the human ABCG2 multidrug transporter. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(2). 477–487. 22 indexed citations

Telbisz, Ágnes, Csilla Hegedüs, András Váradi, Balázs Sarkadi, & Csilla Özvegy‐Laczka. (2014). Regulation of the Function of the Human ABCG2 Multidrug Transporter by Cholesterol and Bile Acids: Effects of Mutations in Potential Substrate and Steroid Binding Sites. Drug Metabolism and Disposition. 42(4). 575–585. 33 indexed citations

Hegedüs, Csilla, Anna Brózik, Ildikó Kasza, et al.. (2012). PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter. Biochemical and Biophysical Research Communications. 420(4). 869–874. 13 indexed citations

Hegedüs, Csilla, György Várady, Katalin Német, et al.. (2012). Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance. Biochemical Pharmacology. 84(3). 260–267. 59 indexed citations

Telbisz, Ágnes, Csilla Hegedüs, Csilla Özvegy‐Laczka, et al.. (2011). Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter. European Journal of Pharmaceutical Sciences. 45(1-2). 101–109. 34 indexed citations

Brózik, Anna, Csilla Hegedüs, Zsuzsa Erdei, et al.. (2011). Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?. Expert Opinion on Drug Metabolism & Toxicology. 7(5). 623–642. 98 indexed citations

10.

Özvegy‐Laczka, Csilla, Csilla Hegedüs, Gergely Szakács, & Balázs Sarkadi. (2009). Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?. Current Cancer Drug Targets. 9(3). 252–272. 42 indexed citations

11.

Hegedüs, Csilla, Ágota Apáti, Katalin Német, Csilla Özvegy‐Laczka, & Balázs Sarkadi. (2008). Distinct interaction profiles of the second generation Bcr-Abl inhibitors nilotinib and bosutinib with the ABCG2 multidrug transporter. Cancer Research. 68. 1 indexed citations

12.

Özvegy‐Laczka, Csilla, Rozália Laczkó, Csilla Hegedüs, et al.. (2008). Interaction with the 5D3 Monoclonal Antibody Is Regulated by Intramolecular Rearrangements but Not by Covalent Dimer Formation of the Human ABCG2 Multidrug Transporter. Journal of Biological Chemistry. 283(38). 26059–26070. 34 indexed citations

13.

Hegedüs, Csilla, Gergely Szakács, László Homolya, et al.. (2008). Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays. Advanced Drug Delivery Reviews. 61(1). 47–56. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact